{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T10:34:13Z","timestamp":1760783653424},"reference-count":30,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2013,3,8]],"date-time":"2013-03-08T00:00:00Z","timestamp":1362700800000},"content-version":"vor","delay-in-days":10203,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Journal of Clinical Pharma"],"published-print":{"date-parts":[[1985,4]]},"abstract":"<jats:p>The comparative effects of diltiazem and verapamil in 30 patients with long\u2010standing atrial fibrillation were evaluated in a prospective clinical trial. After a one\u2010 to two\u2010day washout period during which drugs other than digoxin were withdrawn, patients were randomly assigned to diltiazem or verapamil treatment groups. All therapy was double blind. Both drugs were given in ascending doses as follows: days 1\u20136 (part I): diltiazem, 180 mg\/d, or verapamil, 240 mg\/d; days 7\u201312 (part II): diltiazem, 360 mg\/d, or verapamil, 480 mg\/d. Patients failing to convert to sinus rhythm after 12 days had dosage reduced to 180 mg\/d of diltiazem or 240 mg\/d of verapamil, and quinidine, 750 mg\/d, was coadministered for another six days (part III). Medication compliance was verified by frequent measurement of serum drug concentrations. Three verapamil patients dropped out during part I due to adverse reactions (dyspnea, pulmonary congestion, skin rash, or hepatotoxicity). The higher dosage of either verapamil or diltiazem in part II was not well tolerated, and in eight patients part III had to be initiated early due to symptomatic bradycardia. Only one patient in the diltiazem group converted to sinus rhythm, whereas five converted with verapamil (two with verapamil alone, three when combined with quinidine). Thus, diltiazem and verapamil alone are unlikely to convert atrial fibrillation to sinus rhythm. The combination of verapamil and quinidine, however, is a potentially useful pharmacologic approach, having converted atrial fibrillation to sinus rhythm in nearly 50% of patients.<\/jats:p>","DOI":"10.1002\/j.1552-4604.1985.tb02826.x","type":"journal-article","created":{"date-parts":[[2013,3,9]],"date-time":"2013-03-09T00:35:50Z","timestamp":1362789350000},"page":"204-209","source":"Crossref","is-referenced-by-count":17,"title":["Diltiazem, Verapamil, and Quinidine in Patients With Chronic Atrial Fibrillation"],"prefix":"10.1002","volume":"25","author":[{"given":"H.R.","family":"Ochs","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Anda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Eichelbaum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"DJ.","family":"Greenblatt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2013,3,8]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-8703(82)90236-8"},{"key":"e_1_2_1_3_2","first-page":"134","volume-title":"Atrial Fibrillation.","author":"Godtfredsen J","year":"1981"},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-8703(80)90215-X"},{"key":"e_1_2_1_5_2","first-page":"31","article-title":"Enhancement of the antifibrillatory efficacy of quinidine in atrial fibrillation by verapamil","volume":"71","author":"G\u00fclker H","year":"1982","journal-title":"Zeit f\u00fcr Kardiol"},{"key":"e_1_2_1_6_2","first-page":"196","article-title":"Kombinierte Behandlung chronischer Vorhof\u2010Rhythmusst\u00f6rungen mit Chinidin\u2010Verapamil","volume":"75","author":"G\u00fclker H","year":"1980","journal-title":"Med Klin"},{"key":"e_1_2_1_7_2","first-page":"383","article-title":"Kombinierte Anwendung von Chinidin und Verapamil bei chronischem Vorhofflimmern und \u03b2\u2010flattern","volume":"124","author":"Beck OA","year":"1982","journal-title":"M\u00fcnch Med Wschr"},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2008-1070140"},{"key":"e_1_2_1_9_2","first-page":"1792","article-title":"Kombinierte Behandlung des Vorhofflimmerns und anderer tachykarder Rhythmusst\u00f6rungen mit Chinidin und Verapamil","volume":"23","author":"Heilmann E","year":"1972","journal-title":"Med Welt"},{"key":"e_1_2_1_10_2","first-page":"1670","article-title":"Die Behandlung des chronischen Vorhofflimmerns mit einer Kombination von Chinidin und Verapamil","volume":"21","author":"Belz GG","year":"1970","journal-title":"Med Welt"},{"key":"e_1_2_1_11_2","first-page":"37","volume-title":"New Calcium Antagonists: Recent Developments and Prospects.","author":"Taira N","year":"1980"},{"key":"e_1_2_1_12_2","first-page":"213","volume-title":"New Calcium Antagonists: Recent Developments and Prospects.","author":"Treese N","year":"1983"},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.53.2.273"},{"key":"e_1_2_1_14_2","first-page":"262","article-title":"Increased clearance of digoxin in rabbits during repeated administration","volume":"204","author":"Ochs HR","year":"1978","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_1_15_2","first-page":"1093","article-title":"A homogenous enzyme immunoassay for quinidine in serum","volume":"25","author":"Collins C","year":"1979","journal-title":"Clin Chem"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01716446"},{"key":"e_1_2_1_17_2","first-page":"972","article-title":"The pharmacokinetic model of diltiazem","volume":"33","author":"K\u00f6lle EU","year":"1983","journal-title":"Arzneim Forsch"},{"key":"e_1_2_1_18_2","first-page":"94","article-title":"Determination of verapamil in human plasma by mass fragmentography using stable\u2010labelled verapamil as internal standard","volume":"27","author":"Spiegelholder B","year":"1977","journal-title":"Arzneim Forsch"},{"key":"e_1_2_1_19_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-198005020-00003"},{"key":"e_1_2_1_20_2","first-page":"602","article-title":"Bedeutung des Digitalisplasmaspiegels f\u00fcr die Therapieuberwachung","volume":"16","author":"Ochs HR","year":"1979","journal-title":"Med Weit"},{"key":"e_1_2_1_21_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00568400"},{"key":"e_1_2_1_22_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00568399"},{"key":"e_1_2_1_23_2","first-page":"774","volume-title":"Clinical pharmacology of calcium channel blockers","author":"Eichelbaum M","year":"1984"},{"key":"e_1_2_1_24_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-65-2-216"},{"key":"e_1_2_1_25_2","first-page":"1569","article-title":"Chinidin und Verapamil Kombinationstherapie zur Behandlung von Vorhof\u2010Rhythmusst\u00f6rungen","volume":"38","author":"Kleinebenne A","year":"1981","journal-title":"Fortschr Med"},{"key":"e_1_2_1_26_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198007173030316"},{"key":"e_1_2_1_27_2","first-page":"IV\u201024","article-title":"Effects of various calcium\u2010antagonists on blood level and renal clearance of digoxin (abstract)","volume":"64","author":"Belz GG","year":"1980","journal-title":"Circulation"},{"key":"e_1_2_1_28_2","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1983.55"},{"key":"e_1_2_1_29_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.65.6.1163"},{"key":"e_1_2_1_30_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-94-1-1"},{"key":"e_1_2_1_31_2","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1001\/archinte.1979.03630440017009","article-title":"The beneficial effect of verapamil in chronic atrial fibrillation","volume":"139","author":"Klein HO","year":"1979","journal-title":"Arch Intern Med"}],"container-title":["The Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fj.1552-4604.1985.tb02826.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/accp1.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/j.1552-4604.1985.tb02826.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,20]],"date-time":"2023-10-20T01:31:42Z","timestamp":1697765502000},"score":1,"resource":{"primary":{"URL":"https:\/\/accp1.onlinelibrary.wiley.com\/doi\/10.1002\/j.1552-4604.1985.tb02826.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1985,4]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1985,4]]}},"alternative-id":["10.1002\/j.1552-4604.1985.tb02826.x"],"URL":"https:\/\/doi.org\/10.1002\/j.1552-4604.1985.tb02826.x","archive":["Portico"],"relation":{},"ISSN":["0091-2700","1552-4604"],"issn-type":[{"value":"0091-2700","type":"print"},{"value":"1552-4604","type":"electronic"}],"subject":[],"published":{"date-parts":[[1985,4]]}}}